Treatment
Treatment clinical trials
We’re tracking 8,599 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT06565052Recruiting
Exercise and nutrition before rectal cancer surgery study
This trial tests whether a personalized exercise and nutrition program before rectal cancer surgery can help you recover faster and have fewer complications. If you are not very active right now, you may be able to join.
Boston, MassachusettsAges 18 years+ - NCT06565416Recruiting
Pain & opioid treatment in Native communities
This study is testing better ways to treat pain and opioid use in Native American communities. It may help if you have chronic pain or struggle with opioids.
Arcata, CaliforniaAges 18 years+ - NCT06565845Recruiting
Comparing treatments for granulomatous lobular mastitis
This study looks at different ways to treat granulomatous lobular mastitis (GLM), a type of breast inflammation that is not an infection. The goal is to find which treatment works best for people with this condition.
Harbin, HeilongjiangAges 15–65 - NCT06566755RecruitingPhase 3
New drug combo for a common type of colorectal cancer
This trial tests a combination of a new immunotherapy (cadonilimab) with standard chemotherapy (capecitabine, oxaliplatin) and bevacizumab for people with metastatic colorectal cancer that has a RAS mutation or is located on the right side of the colon. The goal is to see if this combination works better than the current standard of care as a first treatment.
Shenyang, LiaoningAges 18–75 - NCT06566586RecruitingPhase 2
Study of TQB3702 plus immunochemotherapy for B-cell lymphoma
This trial tests a new tablet (TQB3702) combined with standard immune-and-chemo therapy for certain types of B-cell lymphoma that have come back or not responded to previous treatment. It aims to see if the combination is safe and effective.
Beijing, Beijing MunicipalityAges 18–75 - NCT06566807RecruitingPhase 2
Orelabrutinib plus obinutuzumab for marginal zone lymphoma
This trial tests a combination of two targeted drugs (orelabrutinib and obinutuzumab) as a first treatment for marginal zone lymphoma that has returned or progressed after local therapy. The goal is to see if this combination works better than current options.
Huai'an, JiangsuAges 18 years+ - NCT06567145Recruiting
Group therapy for self-stigma in mental health
This study tests a group therapy program designed to help people with mental health conditions reduce the shame and stigma they feel about their illness. It takes place in northeastern Italy and is for people who are stable on their current medications.
VeronaAges 18 years+ - NCT06567197Recruiting
MS treatment with stem cell transplant in the Netherlands
This trial studies a stem cell transplant treatment for relapsing-remitting multiple sclerosis (RRMS). It aims to see how well this therapy works for people in the Netherlands who have already been approved for it.
AmsterdamAges 18–65 - NCT06567210Recruiting
Insomnia treatment and emotional memory regulation for mental health
This study tests whether treating insomnia can help regulate emotional memories overnight, which may reduce the risk of developing or worsening mental health conditions. You may be eligible if you have both insomnia and some anxiety symptoms.
Macquarie Park, New South WalesAges 18–45 - NCT06567353Recruiting
Heat-based immunotherapy for breast cancer liver metastases
This trial tests a new treatment that uses heat to target liver tumors and boost the immune system. It is for women with breast cancer that has spread to the liver who cannot have or do not want surgery.
ShanghaiAges 18–75 - NCT06567535Recruiting
Nerve-sparing surgery for jaw cysts using a camera and navigation
This trial tests a new way to remove jaw cysts using a tiny camera and special guides, which may help protect the nerve in your jaw. It is for people with a tooth-related cyst at least 2 cm wide that is pushing on that nerve.
Guangzhou, GuangdongAges 18–75 - NCT06568159Recruiting
Sleep apnea treatment in heart patients
This study looks at how well people with heart disease or high heart risk follow their sleep apnea treatment, comparing a mouth device (MAD) to a CPAP machine. It aims to find which treatment works better for daily use.
MontpellierAges 18 years+ - NCT06569459RecruitingPhase 2
Trilaciclib with chemoradiation and immunotherapy for esophageal cancer
This trial tests an investigational drug called trilaciclib added to standard chemoradiation and immunotherapy for locally advanced esophageal cancer that cannot be surgically removed. The goal is to see if this combination improves treatment outcomes.
Nanjing, JiangsuAges 18 years+ - NCT06569693Recruiting
Sleep study for people with GI cancer and their partners
This study tests whether couples (one with a GI cancer and their sleep partner) can improve their sleep together. It involves a sleep program to help both partners build healthier sleep habits.
Coral Gables, FloridaAges 18 years+ - NCT06569966Recruiting
Bowel rehab before ileostomy closure after rectal cancer surgery
This study tests two ways of giving back the fluid from your small intestine (ileal contents) through an enema or reinfusion before your ileostomy is closed. The goal is to see which method helps your bowel movements return to normal after rectal cancer surgery.
Qingdao, ShandongAges 18–85 - NCT06569953RecruitingPhase 4
Numbing Medicine for Pain After Lung Surgery
This study tests whether a long-lasting numbing medicine (liposomal bupivacaine) injected near the spine can better control pain after lung surgery. It compares this to a standard numbing medicine, and aims to help patients recover with less pain after surgery.
Chongqing, Chongqing MunicipalityAges 18 years+ - NCT06570005Recruiting
Testing a water quality assurance fund in Ghana and Kenya
This trial tests a program to help improve water quality in Ghana and Kenya. It checks if a 'Water Quality Assurance Fund' helps keep water systems safe and reliable.
AccraAges 18 years+ - NCT06570291RecruitingPhase 3
Stem cell injection for knee osteoarthritis
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
Shanghai, ChinaAges 40–75 - NCT06570980Recruiting
Comparing two diabetes drugs taken with metformin
This study looks at two common diabetes pills (sulfonylureas and DPP4 inhibitors) when used together with metformin. It aims to find out which combination is more cost-effective for treating type 2 diabetes.
DhakaAges 18 years+ - NCT06571734RecruitingPhase 2
XL092 for advanced sarcoma types
This trial tests an experimental drug called XL092 (zanzalintinib) for people with advanced leiomyosarcoma, bone sarcoma, or translocation-associated soft tissue sarcoma that has spread or cannot be removed by surgery. The drug is a type of targeted therapy that may stop cancer growth.
Chicago, IllinoisAges 18 years+ - NCT06572618RecruitingPhase 2
Nemtabrutinib plus rituximab for first-line mantle cell lymphoma
This trial tests a new combination of two drugs, nemtabrutinib (a targeted pill) and rituximab (an antibody infusion), for people with mantle cell lymphoma (MCL) who haven't had prior treatment. The goal is to see how well these drugs work together to control the lymphoma.
Duarte, CaliforniaAges 18 years+ - NCT06572605RecruitingPhase 1/Phase 2
Radiation plus talquetamab for myeloma outside the bone
This trial tests combining radiation therapy with a targeted drug called talquetamab for multiple myeloma that has formed tumors outside the bone (extramedullary disease). It aims to see if this combination can shrink or control these tumors and improve outcomes.
Duarte, CaliforniaAges 18 years+ - NCT06573437Recruiting
VESTO vascular stent for leg artery blockages
This study tests a new stent (a tiny mesh tube) to open blocked arteries in the pelvis or thigh area. It may help improve blood flow and reduce leg pain or wounds.
Salvador, Estado de BahiaAges 18 years+ - NCT06573476Recruiting
Smartphone app and peer coach for opioid treatment
This study tests whether a smartphone app and support from a peer recovery coach can help Black and Latinx individuals with opioid use disorder start buprenorphine treatment. The goal is to reduce overdose deaths and address racial gaps in care.
New York, New YorkAges 18–99
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,599 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.